ラットモデル市場規模、シェア、動向分析レポート：タイプ別、技術別、サービス別、用途別、最終用途別、地域別、セグメント予測、2023年～2030年

ラットモデル市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のラットモデル市場規模は2030年までに24億1,000万米ドルに達し、2023年から2030年までのCAGRは7.06％で拡大すると予測されています。

遺伝子組換え生物は、潜在的な治療標的の同定とそのさらなる検証のための調査で広く使用されています。ヘルスケアに基づく広範な調査が、ヒトの病気や遺伝的疾患を理解するための市場を牽引しています。

COVID-19の発生中、研究者たちは、in-vitroおよびex-vivo培養システムに加えて、容易に入手可能な動物モデルを使用することにより、SARS-CoV2ウイルスの病原および伝播の理解に焦点を当てた。これらのモデルは、ワクチンや抗ウイルス剤の評価にも役立っています。トランスジェニック動物を作製している企業は、これを絶好の機会として、SARS-Cov2ウイルスの侵入を評価するための遺伝子組み換えラットを科学界に提供しました。例えば、2020年、エンヴィゴ社はCRISPRベースの技術によってhACE2ノックインラットモデルを作成しました。一次受容体として機能するACE2はSARS-CoV2ウイルスの侵入を促進し、潜在的な予防標的として研究されています。

動物モデルは、潜在的な治療薬の前臨床試験や疾病メカニズムの理解のための重要なツールであり続けています。研究費の増加と臨床試験件数の増加が市場成長の主な要因です。遺伝性疾患の世界の罹患率の上昇と、様々な画期的な治療法を推進するための動物種の利用の急増は、市場成長をさらに促進すると予想されます。2003年にヒトゲノム・プロジェクトが完了した後、病気の遺伝的基盤を理解するための合成生物学や分子生物学が明らかに進歩しました。これらの先端技術や製品により、遺伝子操作モデルラット（GEM）の作製も容易になり、ノックアウト、アウトブリード、インブリード、コンディションドなど、さまざまなタイプが市場で入手できるようになっています。

市場はマウス/マウスモデルとの直接競合が予想されます。マウスモデルはサイズが小さいため、長い間好まれており、経済的であると同時に、発見や初期段階の研究により確立された選択肢を提供しています。しかし、ラットにおける遺伝子編集ツールの膨大な使用やラットとヒトのゲノムの類似性により、ラットモデルは遺伝子操作や実験の取り扱いに適しており、市場拡大に拍車をかけています。

ラットモデル市場レポートハイライト

• タイプ別では、近交系ラットが2022年に最大のシェアを占めました。これは、近交系ラットにおける遺伝子の変化がヒトと生理学的に類似しているためであり、これが疾患の表現型に帰結します。
• 技術別では、その他の技術（CRISPR/Cas、ZFNなど）が2022年に最大のシェアを占めました。ゲノム編集ツールの登場により、研究用途に応じたカスタムラットモデルの作製が可能になり、市場需要に寄与しています。
• サービス別では、繁殖分野が2022年の市場を独占しました。これは、個体群間の遺伝的変異を評価する実験において、複数のラットモデルの需要が高いためです。
• 用途別では、2022年には毒物学が最大のシェアを占めました。医薬品や治療薬の需要のため、ラットを用いた毒性学研究は、前臨床段階での投与量や投与経路など様々な要因の分析に役立ちます。
• 最終用途別では、受託研究機関が2022年に最大のシェアを占めました。強固な研究開発環境と複数の創薬プログラムおよび臨床試験が、このセグメントの成長に拍車をかけています。これらの活動では、あらゆる治療中のヒトの反応を模倣するために、多数のラットモデルを採用しています。
• 北米は2022年に最大の収益シェアを占めました。この地域での疾病の有病率の増加とヘルスケア機関のこの分野への注力は、ラットを用いた研究を促進するための学術機関への複数の資金提供をもたらしました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ラットモデルの市場変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• ラットモデル市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 ラットモデル：タイプの推定・動向分析

• ラットモデル市場、重要なポイント
• ラットモデル市場：動向と市場シェア分析、2022年と2030年
• ノックアウト
  • ノックアウト市場推計・予測、2018年から2030年まで
• 異系交配
  • 異系交配市場推計・予測、2018年から2030年まで
• 近交系
  • 近交系市場推計・予測、2018年から2030年まで
• ハイブリッド
  • ハイブリッド市場推計・予測、2018年から2030年まで
• 免疫不全
  • 免疫不全市場推計・予測、2018年から2030年まで
• 条件付き
  • 条件付き市場推計・予測、2018年から2030年まで

第5章 ラットモデル：技術の推定・動向分析

• ラットモデル市場、重要なポイント
• ラットモデル市場：動向と市場シェア分析、2022年および2030年
• 核転移酵素
• マイクロインジェクション
• 胚性幹細胞
• その他

第6章 ラットモデル：サービスの推定・動向分析

• ラットモデル市場、重要なポイント
• ラットモデル市場：動向と市場シェア分析、2022年と2030年
• 冷凍保存
  • 冷凍保存市場推計・予測、2018年から2030年まで
• 育種
  • 育種市場推計・予測、2018年から2030年まで
• 再導出
  • 再導出市場推計・予測、2018年から2030年まで
• 遺伝子検査
  • 遺伝子検査市場推計・予測、2018年から2030年まで
• 隔離
  • 隔離市場推計・予測、2018年から2030年まで
• その他
  • その他の市場推計・予測、2018年から2030年

第7章 ラットモデル：用途の推定・動向分析

• ラットモデル市場、重要なポイント
• ラットモデル市場：動向と市場シェア分析、2022年および2030年
• オンコロジー
• 神経内科
• 免疫
• 毒物
• その他

第8章 ラットモデル：最終用途の推定・動向分析

• ラットモデル市場、重要なポイント
• ラットモデル市場：動向と市場シェア分析、2022年と2030年
• CRO
  • CRO市場推計・予測、2018年から2030年まで
• 学術研究機関
  • 学術研究機関の市場推計・予測、2018年から2030年まで
• 製薬およびバイオテクノロジー企業
  • 製薬およびバイオテクノロジー企業の市場推計・予測と2018年から2030年

第9章 ラットモデル市場：地域推定・動向分析

• 地域別の見通し
• 地域別のラットモデル市場：重要なポイント
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第10章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 市場参入企業の分類
  • Charles River Laboratories
  • genOway
  • TransViragen, Inc
  • Laboratory Corporation of America Holdings (LabCorp)
  • Janvier Labs
  • Taconic Biosciences, Inc
  • Biomere
  • Cyagen Biosciences

List of Tables

• Table 1 List of abbreviation
• Table 2 North America rat model market, by type, 2018 - 2030 (USD Million)
• Table 3 North America rat model market, by technology, 2018 - 2030 (USD Million)
• Table 4 North America rat model market, by service, 2018 - 2030 (USD Million)
• Table 5 North America rat model market, by application, 2018 - 2030 (USD Million)
• Table 6 North America rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 7 North America rat model market, by region, 2018 - 2030 (USD Million)
• Table 8 U.S. rat model market, by type, 2018 - 2030 (USD Million)
• Table 9 U.S. rat model market, by technology, 2018 - 2030 (USD Million)
• Table 10 U.S. rat model market, by service, 2018 - 2030 (USD Million)
• Table 11 U.S. rat model market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 13 Canada rat model market, by type, 2018 - 2030 (USD Million)
• Table 14 Canada rat model market, by technology, 2018 - 2030 (USD Million)
• Table 15 Canada rat model market, by service, 2018 - 2030 (USD Million)
• Table 16 Canada rat model market, by application, 2018 - 2030 (USD Million)
• Table 17 Canada rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 18 Europe rat model market, by type, 2018 - 2030 (USD Million)
• Table 19 Europe rat model market, by technology, 2018 - 2030 (USD Million)
• Table 20 Europe rat model market, by service, 2018 - 2030 (USD Million)
• Table 21 Europe rat model market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 23 Europe rat model market, by region, 2018 - 2030 (USD Million)
• Table 24 UK rat model market, by type, 2018 - 2030 (USD Million)
• Table 25 UK rat model market, by technology, 2018 - 2030 (USD Million)
• Table 26 UK rat model market, by service, 2018 - 2030 (USD Million)
• Table 27 UK rat model market, by application, 2018 - 2030 (USD Million)
• Table 28 UK rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 29 Germany rat model market, by type, 2018 - 2030 (USD Million)
• Table 30 Germany rat model market, by technology, 2018 - 2030 (USD Million)
• Table 31 Germany rat model market, by service, 2018 - 2030 (USD Million)
• Table 32 Germany rat model market, by application, 2018 - 2030 (USD Million)
• Table 33 Germany rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 34 France rat model market, by type, 2018 - 2030 (USD Million)
• Table 35 France rat model market, by technology, 2018 - 2030 (USD Million)
• Table 36 France rat model market, by service, 2018 - 2030 (USD Million)
• Table 37 France rat model market, by application, 2018 - 2030 (USD Million)
• Table 38 France rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 39 Italy rat model market, by type, 2018 - 2030 (USD Million)
• Table 40 Italy rat model market, by technology, 2018 - 2030 (USD Million)
• Table 41 Italy rat model market, by service, 2018 - 2030 (USD Million)
• Table 42 Italy rat model market, by application, 2018 - 2030 (USD Million)
• Table 43 Italy rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 44 Spain rat model market, by type, 2018 - 2030 (USD Million)
• Table 45 Spain rat model market, by technology, 2018 - 2030 (USD Million)
• Table 46 Spain rat model market, by service, 2018 - 2030 (USD Million)
• Table 47 Spain rat model market, by application, 2018 - 2030 (USD Million)
• Table 48 Spain rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Sweden rat model market, by type, 2018 - 2030 (USD Million)
• Table 50 Sweden rat model market, by technology, 2018 - 2030 (USD Million)
• Table 51 Sweden rat model market, by service, 2018 - 2030 (USD Million)
• Table 52 Sweden rat model market, by application, 2018 - 2030 (USD Million)
• Table 53 Sweden rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 54 Norway rat model market, by type, 2018 - 2030 (USD Million)
• Table 55 Norway rat model market, by technology, 2018 - 2030 (USD Million)
• Table 56 Norway rat model market, by service, 2018 - 2030 (USD Million)
• Table 57 Norway rat model market, by application, 2018 - 2030 (USD Million)
• Table 58 Norway rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 59 Denmark rat model market, by type, 2018 - 2030 (USD Million)
• Table 60 Denmark rat model market, by technology, 2018 - 2030 (USD Million)
• Table 61 Denmark rat model market, by service, 2018 - 2030 (USD Million)
• Table 62 Denmark rat model market, by application, 2018 - 2030 (USD Million)
• Table 63 Denmark rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific rat model market, by type, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific rat model market, by technology, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific rat model market, by service, 2018 - 2030 (USD Million)
• Table 67 Asia Pacific rat model market, by application, 2018 - 2030 (USD Million)
• Table 68 Asia Pacific rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific rat model market, by region, 2018 - 2030 (USD Million)
• Table 70 Japan rat model market, by type, 2018 - 2030 (USD Million)
• Table 71 Japan rat model market, by technology, 2018 - 2030 (USD Million)
• Table 72 Japan rat model market, by service, 2018 - 2030 (USD Million)
• Table 73 Japan rat model market, by application, 2018 - 2030 (USD Million)
• Table 74 Japan rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 75 China rat model market, by type, 2018 - 2030 (USD Million)
• Table 76 China rat model market, by technology, 2018 - 2030 (USD Million)
• Table 77 China rat model market, by service, 2018 - 2030 (USD Million)
• Table 78 China rat model market, by application, 2018 - 2030 (USD Million)
• Table 79 China rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 80 India rat model market, by type, 2018 - 2030 (USD Million)
• Table 81 India rat model market, by technology, 2018 - 2030 (USD Million)
• Table 82 India rat model market, by service, 2018 - 2030 (USD Million)
• Table 83 India rat model market, by application, 2018 - 2030 (USD Million)
• Table 84 India rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 85 Australia rat model market, by type, 2018 - 2030 (USD Million)
• Table 86 Australia rat model market, by technology, 2018 - 2030 (USD Million)
• Table 87 Australia rat model market, by service, 2018 - 2030 (USD Million)
• Table 88 Australia rat model market, by application, 2018 - 2030 (USD Million)
• Table 89 Australia rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Thailand rat model market, by type, 2018 - 2030 (USD Million)
• Table 91 Thailand rat model market, by technology, 2018 - 2030 (USD Million)
• Table 92 Thailand rat model market, by service, 2018 - 2030 (USD Million)
• Table 93 Thailand rat model market, by application, 2018 - 2030 (USD Million)
• Table 94 Thailand rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 95 South Korea rat model market, by type, 2018 - 2030 (USD Million)
• Table 96 South Korea rat model market, by technology, 2018 - 2030 (USD Million)
• Table 97 South Korea rat model market, by service, 2018 - 2030 (USD Million)
• Table 98 South Korea rat model market, by application, 2018 - 2030 (USD Million)
• Table 99 South Korea rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 100 Latin America rat model market, by type, 2018 - 2030 (USD Million)
• Table 101 Latin America rat model market, by technology, 2018 - 2030 (USD Million)
• Table 102 Latin America rat model market, by service, 2018 - 2030 (USD Million)
• Table 103 Latin America rat model market, by application, 2018 - 2030 (USD Million)
• Table 104 Latin America rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 105 Latin America rat model market, by region, 2018 - 2030 (USD Million)
• Table 106 Brazil rat model market, by type, 2018 - 2030 (USD Million)
• Table 107 Brazil rat model market, by technology, 2018 - 2030 (USD Million)
• Table 108 Brazil rat model market, by service, 2018 - 2030 (USD Million)
• Table 109 Brazil rat model market, by application, 2018 - 2030 (USD Million)
• Table 110 Brazil rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 111 Mexico rat model market, by type, 2018 - 2030 (USD Million)
• Table 112 Mexico rat model market, by technology, 2018 - 2030 (USD Million)
• Table 113 Mexico rat model market, by service, 2018 - 2030 (USD Million)
• Table 114 Mexico rat model market, by application, 2018 - 2030 (USD Million)
• Table 115 Mexico rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 116 Argentina rat model market, by type, 2018 - 2030 (USD Million)
• Table 117 Argentina rat model market, by technology, 2018 - 2030 (USD Million)
• Table 118 Argentina rat model market, by service, 2018 - 2030 (USD Million)
• Table 119 Argentina rat model market, by application, 2018 - 2030 (USD Million)
• Table 120 Argentina rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 121 Middle East and Africa rat model market, by type, 2018 - 2030 (USD Million)
• Table 122 Middle East and Africa rat model market, by technology, 2018 - 2030 (USD Million)
• Table 123 Middle East and Africa rat model market, by service, 2018 - 2030 (USD Million)
• Table 124 Middle East and Africa rat model market, by application, 2018 - 2030 (USD Million)
• Table 125 Middle East and Africa rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 126 Middle East and Africa rat model market, by region, 2018 - 2030 (USD Million)
• Table 127 Saudi Arabia rat model market, by type, 2018 - 2030 (USD Million)
• Table 128 Saudi Arabia rat model market, by technology, 2018 - 2030 (USD Million)
• Table 129 Saudi Arabia rat model market, by service, 2018 - 2030 (USD Million)
• Table 130 Saudi Arabia rat model market, by application, 2018 - 2030 (USD Million)
• Table 131 Saudi Arabia rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 132 South Africa rat model market, by type, 2018 - 2030 (USD Million)
• Table 133 South Africa rat model market, by technology, 2018 - 2030 (USD Million)
• Table 134 South Africa rat model market, by service, 2018 - 2030 (USD Million)
• Table 135 South Africa rat model market, by application, 2018 - 2030 (USD Million)
• Table 136 South Africa rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 137 UAE rat model market, by type, 2018 - 2030 (USD Million)
• Table 138 UAE rat model market, by technology, 2018 - 2030 (USD Million)
• Table 139 UAE rat model market, by service, 2018 - 2030 (USD Million)
• Table 140 UAE rat model market, by application, 2018 - 2030 (USD Million)
• Table 141 UAE rat model market, by end-use, 2018 - 2030 (USD Million)
• Table 142 Kuwait rat model market, by type, 2018 - 2030 (USD Million)
• Table 143 Kuwait rat model market, by technology, 2018 - 2030 (USD Million)
• Table 144 Kuwait rat model market, by service, 2018 - 2030 (USD Million)
• Table 145 Kuwait rat model market, by application, 2018 - 2030 (USD Million)
• Table 146 Kuwait rat model market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Rat model: Market outlook
• Fig. 9 Rat model: Competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Rat model market driver impact
• Fig. 15 Rat model market restraint impact
• Fig. 16 Rat model market strategic initiatives analysis
• Fig. 17 Rat model market: Type movement analysis
• Fig. 18 Rat model market: Type outlook and key takeaways
• Fig. 19 Knockout market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Outbred market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Inbred market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Hybrid market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Immunodeficient market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Conditioned market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Rat model market: Technology movement analysis
• Fig. 26 Rat model market: Technology outlook and key takeaways
• Fig. 27 Nuclear transferase market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Microinjection market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Embryonic stem cell market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Rat model market: Service movement analysis
• Fig. 32 Rat model market: Service outlook and key takeaways
• Fig. 33 Cryopreservation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Breeding market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Re-derivation market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Genetic testing market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Quarantine depending market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Other market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Rat model market: Application movement analysis
• Fig. 40 Rat model market: Application outlook and key takeaways
• Fig. 41 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Neurology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Immunology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Toxicology market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Other market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Rat model market: End-use movement analysis
• Fig. 47 Rat model market: End-use outlook and key takeaways
• Fig. 48 CROs market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Academic and research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Global rat model market: Regional movement analysis
• Fig. 52 Global rat model market: Regional outlook and key takeaways
• Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Rat Model Market Growth & Trends:

The global rat model market size is expected to reach USD 2.41 billion by 2030, according to a new report by Grand View Research, Inc.., expanding at a CAGR of 7.06% from 2023 to 2030. Genetically modified organisms are extensively used in research for identifying potential therapeutic targets and further validation of the same. The extensive healthcare-based research has driven the market for understanding diseases and genetic illnesses of humans.

During the COVID-19 outbreak, researchers were focused on understanding the pathogenesis and transmission of the SARS-CoV2 virus by using the readily available animal model in addition to in-vitro and ex-vivo culture systems. These models also helped in the evaluation of vaccines and antivirals for the treatment. Companies creating transgenic animals used this as a perfect opportunity to provide the scientific community with genetically modified rats for evaluation of SARS-Cov2 entry. For example, in 2020,Envigo created the hACE2 knockinrat model through CRISPR-based technology. ACE2 serving as a primary receptor facilitates the entry of the SARS-CoV2 virus and is being investigated as a potential preventative target.

Animal models continue to be significant tools for preclinical testing of potential therapeutics and understanding disease mechanisms. Increased spending on research and growing number of clinical trials are the key factors contributing to the market growth. The rising incidence of genetic diseases globally and the surge in the use of animal species to advance various groundbreaking therapies are expected to further propel the market growth. Post completion of The Human Genome Project in 2003, there have been evident advancements in synthetic and molecular biology for understanding the genetic basis of diseases. These advanced technologies and products have also made it easier to create genetically engineered models (GEM) of rats, wherein different types such as knockout, outbred, inbred, and conditioned are now available in the market.

The market is expected to observe direct competition from the mouse/mice model. The mice models have been long preferred due to their small sizes and they offer economic as well as more established choices for discovery and early stage research. However, the vast use of gene editing tools in rats and the similarity of rat and human genomes make the rat model suitable for genetic manipulation and handling of experiments, thus fueling the market expansion.

Rat Model Market Report Highlights:

• By type, outbred rat held the largest share in 2022. This is due to the physiological similarity of gene changes in outbred rats as in humans, which attributes to a disease phenotype
• By technology, other technologies (CRISPR/Cas, ZFN, and more)accounted for the largest share in 2022. The advent of genome editing tools has led to custom rat model creation according to the research application, thus contributing to the market demand
• By service, the breeding segment dominated the market in 2022. This is due to the high demand for multiple rat models during experiments to assess genetic variations among a population pool
• By application, in 2022, toxicology held the largest share. Owing to the demand for medications and therapeutics, toxicology studies in rats help analyze various factors such as dosing and route of administration during preclinical stages
• By end-use, the contract research organizations held the largest share in 2022.The robust R&D settings and the multiple drug discovery programs and clinical trials are fueling the segment growth. These activities employ a wide number of rat models to mimic the human response during any treatment
• North America held the largest revenue share in 2022. Growing prevalence of diseases in this region, coupled with the focus of healthcare agencies on this, has resulted in multiple funding to academic institutes for facilitating research in rats

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Technology
  • 1.1.3. Service
  • 1.1.4. Application
  • 1.1.5. End-use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Technology outlook
  • 2.2.3. Service outlook
  • 2.2.4. Application outlook
  • 2.2.5. End-use outlook
  • 2.2.6. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Rat Model Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
  • 3.3.2. Market restraint analysis
• 3.4. Rat Model Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Rat Model: Type Estimates & Trend Analysis

• 4.1. Rat Model Market, Key Takeaways
• 4.2. Rat Model Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Knockout
  • 4.3.1. Knockout market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.4. Outbred
  • 4.4.1. Outbred market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. Inbred
  • 4.5.1. Inbred market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Hybrid
  • 4.6.1. Hybrid market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.7. Immunodeficient
  • 4.7.1. Immunodeficient market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.8. Conditioned
  • 4.8.1. Conditioned market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Rat Model: Technology Estimates & Trend Analysis

• 5.1. Rat Model Market, Key Takeaways
• 5.2. Rat Model Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. Nuclear Transferase
  • 5.3.1. Nuclear transferase market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.4. Microinjection
  • 5.4.1. Microinjection market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Embryonic Stem Cell
  • 5.5.1. Embryonic stem cell market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Rat Model: Service Estimates & Trend Analysis

• 6.1. Rat Model Market, Key Takeaways
• 6.2. Rat Model Market: Movement & Market Share Analysis, 2022 & 2030
• 6.3. Cryopreservation
  • 6.3.1. Cryopreservation market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.4. Breeding
  • 6.4.1. Breeding market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Re-derivation
  • 6.5.1. Re-derivation market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Genetic Testing
  • 6.6.1. Genetic testing market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Quarantine Depending
  • 6.7.1. Quarantine depending market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.8. Other
  • 6.8.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Rat Model: Application Estimates & Trend Analysis

• 7.1. Rat Model Market, Key Takeaways
• 7.2. Rat Model Market: Movement & Market Share Analysis, 2022 & 2030
• 7.3. Oncology
  • 7.3.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.4. Neurology
  • 7.4.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.5. Immunology
  • 7.5.1. Immunology market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.6. Toxicology
  • 7.6.1. Toxicology market estimates and forecasts, 2018 to 2030 (USD Million)
• 7.7. Other
  • 7.7.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Rat Model: End-use Estimates & Trend Analysis

• 8.1. Rat Model Market, Key Takeaways
• 8.2. Rat Model Market: Movement & Market Share Analysis, 2022 & 2030
• 8.3. CROs
  • 8.3.1. CROs market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.4. Academic and Research Institutes
  • 8.4.1. Academic and research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
• 8.5. Pharmaceutical & Biotechnology Companies
  • 8.5.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Rat Model Market: Regional Estimates & Trend Analysis

• 9.1. Regional Outlook
• 9.2. Rat Model Market by Region: Key Takeaway
• 9.3. North America
  • 9.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4.3. France
    • 9.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4.6. Sweden
    • 9.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4.7. Norway
    • 9.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5.2. China
    • 9.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5.3. India
    • 9.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5.5. Thailand
    • 9.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5.6. South Korea
    • 9.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.6.2. Mexico
    • 9.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
• 9.7. MEA
  • 9.7.1. Saudi Arabia
    • 9.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Market Participant Categorization
  • 10.2.1. Charles River Laboratories
    • 10.2.1.1. Company overview
    • 10.2.1.2. Financial performance
    • 10.2.1.3. Product benchmarking
    • 10.2.1.4. Strategic initiatives
  • 10.2.2. genOway
    • 10.2.2.1. Company overview
    • 10.2.2.2. Financial performance
    • 10.2.2.3. Product benchmarking
    • 10.2.2.4. Strategic initiatives
  • 10.2.3. TransViragen, Inc
    • 10.2.3.1. Company overview
    • 10.2.3.2. Financial performance
    • 10.2.3.3. Product benchmarking
    • 10.2.3.4. Strategic initiatives
  • 10.2.4. Laboratory Corporation of America Holdings (LabCorp)
    • 10.2.4.1. Company overview
    • 10.2.4.2. Financial performance
    • 10.2.4.3. Product benchmarking
    • 10.2.4.4. Strategic initiatives
  • 10.2.5. Janvier Labs
    • 10.2.5.1. Company overview
    • 10.2.5.2. Financial performance
    • 10.2.5.3. Product benchmarking
    • 10.2.5.4. Strategic initiatives
  • 10.2.6. Taconic Biosciences, Inc
    • 10.2.6.1. Company overview
    • 10.2.6.2. Financial performance
    • 10.2.6.3. Product benchmarking
    • 10.2.6.4. Strategic initiatives
  • 10.2.7. Biomere
    • 10.2.7.1. Company overview
    • 10.2.7.2. Financial performance
    • 10.2.7.3. Product benchmarking
    • 10.2.7.4. Strategic initiatives
  • 10.2.8. Cyagen Biosciences
    • 10.2.8.1. Company overview
    • 10.2.8.2. Financial performance
    • 10.2.8.3. Product benchmarking
    • 10.2.8.4. Strategic initiatives